beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 7898484
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statistical analysis of alamethicin channels in black lipid membranes

  2005cited by this paper
• Theoretical models of the ion channel structure of amyloid beta-protein.

  1994cited by this paper
• Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide.

  1993cited by this paper
• Amyloid beta peptides act directly on single neurons.

  1993cited by this paper
• Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF.

  1993cited by this paper
• β‐Amyloid Neurotoxicity in Human Cortical Culture Is Not Mediated by Excitotoxins

  1993cited by this paper
• Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease.

  1993cited by this paper
• Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffraction.

  1993cited by this paper
• beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

  1993cited by this paper
• Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

  1993cited by this paper
• Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

  1993cited by this paper
• Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum.

  1993cited by this paper
• X‐Ray Diffraction Analysis of Brain Lipid Membrane Structure in Alzheimer's Disease and β‐Amyloid Peptide Interactions a

  1993cited by this paper
• Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes.

  1993cited by this paper
• Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide.

  1993cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

  1992cited by this paper
• Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.

  1992cited by this paper
• Effect of beta amyloid peptides on neurons in hippocampal slice cultures.

  1992cited by this paper
• In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment.

  1992cited by this paper
• The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain.

  1992cited by this paper
• beta-Amyloid neurotoxicity: a discussion of in vitro findings.

  1992cited by this paper
• Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain.

  1992cited by this paper
• Alzheimer's disease: a cell biological perspective.

  1992cited by this paper
• beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

  1992cited by this paper
• Commentary and perspective on studies of beta amyloid neurotoxicity.

  1992cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Failure of beta-amyloid protein fragment 25-35 to cause hippocampal damage in the rat.

  1992cited by this paper
• Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

  1991cited by this paper
• Effects of injected Alzheimer beta-amyloid cores in rat brain.

  1991cited by this paper
• pH-dependent structural transitions of Alzheimer amyloid peptides.

  1991cited by this paper
• The control of neuronal Ca2+ homeostasis.

  1991cited by this paper
• The molecular pathology of Alzheimer's disease.

  1991cited by this paper
• In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity.

  1991cited by this paper
• Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons.

  1991cited by this paper
• Nerve growth factor potentiates the neurotoxicity of beta amyloid.

  1990cited by this paper
• Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

  1990cited by this paper
• Genetics and biology of the Alzheimer amyloid precursor.

  1990cited by this paper
• Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.

  1989cited by this paper
• The role of calcium regulation in brain aging: reexamination of a hypothesis

  1989cited by this paper
• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper

• Dynamic modeling of astrocyte-neuron interactions under the influence of Aβ deposition

  2025cites this paper
• Unsaturated Fatty Acids Are Decreased in Aβ Plaques in Alzheimer's Disease

  2025cites this paper
• Screening and function analysis of key genes and signaling pathways in Alzheimer’s disease via next generation sequencing data analysis and bioinformatics approaches

  2025cites this paper
• Rapid antiepileptic activity identification of isopimpinellin using a multi-model of epilepsy based on behavior-biomarker-BBB screening pipeline.

  2025cites this paper
• Towards the Integrative Theory of Alzheimer’s Disease: Linking Molecular Mechanisms of Neurotoxicity, Beta-amyloid Biomarkers, and the Diagnosis

  2022cites this paper
• Two polyphenols isolated from Corallodiscus flabellata B. L. Burtt ameliorate amyloid β-protein induced Alzheimer's disease neuronal injury by improving mitochondrial homeostasis.

  2022cites this paper
• Hyperphosphorylated tau self-assembles into amorphous aggregates eliciting TLR4-dependent responses

  2022cites this paper
• Molecular insights into the primary nucleation of polymorphic amyloid β dimers in DOPC lipid bilayer membrane

  2022cites this paper
• Atomic Insights into Amyloid-Induced Membrane Damage.

  2022cites this paper
• Linnaeite Mineral for NIR Light-Triggered Disruption of Alzheimer's Pore-Forming Aβ Oligomers.

  2022cites this paper
• Calcium Signaling Regulated by Cellular Membrane Systems and Calcium Homeostasis Perturbed in Alzheimer’s Disease

  2022cites this paper
• Intracellular ion changes induced by the exposure to beta-amyloid can be explained by the formation of channels in the lysosomal membranes.

  2021cites this paper
• Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in Alzheimer’s disease

  2021cites this paper
• Formaldehyde‐Crosslinked Nontoxic Aβ Monomers to Form Toxic Aβ Dimers and Aggregates: Pathogenicity and Therapeutic Perspectives

  2021cites this paper
• Synaptic plasticity in Alzheimer’s disease and healthy aging

  2020cites this paper
• Nicotine Promotes AβPP Nonamyloidogenic Processing via RACK1-Dependent Activation of PKC in SH-SY5Y-AβPP695 Cells

  2020cites this paper
• Nanoscale Interplay of Membrane Composition and Amyloid Self-Assembly.

  2020cites this paper
• Flow cytometry method to quantify the formation of beta-amyloid membrane ion channels.

  2020cites this paper
• Degradation Products of Amyloid Protein: Are They The Culprits?

  2020cites this paper
• Multiscale Analysis of the Amyloid Degradation Toxicity Hypothesis of Alzheimer’s Disease

  2020cites this paper
• Cytotoxic species in amyloid-associated diseases: Oligomers or mature fibrils.

  2019cites this paper
• Structures and dynamics of β-barrel oligomer intermediates of amyloid-beta16-22 aggregation.

  2018cites this paper
• How Fluorescent Tags Modify Oligomer Size Distributions of the Alzheimer Peptide

  2018cites this paper
• Amyloid and membrane complexity: The toxic interplay revealed by AFM.

  2018cites this paper
• ANTI-ALZHEIMER ACTIVITY OF TACRINE LOADED METHOXYPOLY (ETHYLENE GLYCOL) POLY (CAPROLACTONE) NANOPARTICLES

  2018cites this paper
• Amyloid Beta Peptide Is Released during Thrombosis in the Skin

  2018cites this paper
• Perforin Promotes Amyloid Beta Internalisation in Neurons

  2017cites this paper
• Fully Atomistic Aβ40 and Aβ42 Oligomers in Water: Observation of Porelike Conformations.

  2017cites this paper
• Interaction of toxic and non-toxic HypF-N oligomers with lipid bilayers investigated at high resolution with atomic force microscopy

  2016cites this paper
• Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.

  2016cites this paper
• Single-cell screening of cytosolic [Ca2+] reveals cell-selective action by the Alzheimer’s Aβ peptide ion channel

  2015cites this paper
• Characterization of the interactions between β‐amyloid peptide and the membranes of human SK‐N‐SH cells

  2015cites this paper
• Electrophysiology of Unconventional Channels and Pores

  2015cites this paper
• Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.

  2015cites this paper
• TEN Nicotinic Cholinergic Mechanisms in Alzheimer ' s Disease

  2015cites this paper
• Harnessing the Power of Fluorination for Protein Engineering

  2014cites this paper
• Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.

  2014cites this paper
• Heat-induced fibrillation of BclXL apoptotic repressor.

  2013cites this paper
• Alzheimer's disease: which type of amyloid-preventing drug agents to employ?

  2013cites this paper
• 2-Phenylbenzofuran derivatives alleviate mitochondrial damage via the inhibition of β-amyloid aggregation.

  2013cites this paper
• Lipid-mediated Protein Signaling

  2013cites this paper
• Biophysical Insights into the Oligomerization of Bclxl Apoptotic Repressor

  2013cites this paper
• Stability of Transmembrane Amyloid β-Peptide and Membrane Integrity Tested by Molecular Modeling of Site-Specific Aβ 42 Mutations

  2013cites this paper
• Membrane-mediated neuroprotection by curcumin from amyloid-β-peptide-induced toxicity.

  2013cites this paper
• The driving force of alpha-synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: key role of ganglioside- and cholesterol-binding domains.

  2013cites this paper
• How the amyloid-β peptide and membranes affect each other: an extensive simulation study.

  2013cites this paper
• Fresh green tea and gallic acid ameliorate oxidative stress in kainic acid-induced status epilepticus.

  2012cites this paper
• Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.

  2012cites this paper
• Alzheimer Aβ peptide interactions with lipid membranes

  2012cites this paper
• Antimicrobial properties of amyloid peptides.

  2012cites this paper
• Probing Structural Features of Alzheimer’s Amyloid-β Pores in Bilayers Using Site-Specific Amino Acid Substitutions

  2012cites this paper
• Hunting the Chameleon: Structural Conformations of the Intrinsically Disordered Protein Alpha‐Synuclein

  2012cites this paper
• Structure and function of Scaptodrosophila lebanonensis alcohol dehydrogenase

  2012cites this paper
• The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization.

  2012cites this paper
• Tau Oligomers Impair Artificial Membrane Integrity and Cellular Viability*

  2012cites this paper
• Molecular interactions of Alzheimer's Aβ protofilaments with lipid membranes.

  2012cites this paper
• Extraneuronal toxicity of Alzheimer's β‐amyloid peptide: Comparative study on vertebrate skeletal muscles

  2011cites this paper
• Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues.

  2011cites this paper
• Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine.

  2011cites this paper
• Mechanisms underlying basal and learning-related intrinsic excitability in a mouse model of Alzheimer's disease.

  2011cites this paper
• Antimicrobial protegrin-1 forms amyloid-like fibrils with rapid kinetics suggesting a functional link.

  2011cites this paper
• Antidepressants Modulate Intracellular Amyloid Peptide Species in N2a Neuroblastoma Cells

  2011cites this paper
• Pu-Erh tea and GABA attenuates oxidative stress in kainic acid-induced status epilepticus

  2011cites this paper
• Effect of cadmium ions on amyloid beta peptide 1-42 channel activity

  2011cites this paper
• Probing structural features of amyloid-beta Ion channels in membranes using A-beta mutants

  2011influential citation
• Effects of surface interactions on peptide aggregate morphology.

  2011cites this paper
• Sesamin ameliorates oxidative stress and mortality in kainic acid-induced status epilepticus by inhibition of MAPK and COX-2 activation

  2011cites this paper
• Cholesterol, lipids, amyloid Beta, and Alzheimer's.

  2010cites this paper
• Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases

  2010cites this paper
• β-Barrel topology of Alzheimer's β-amyloid ion channels.

  2010cites this paper
• Structural Convergence Among Diverse, Toxic β-Sheet Ion Channels

  2010cites this paper
• Adult Neurogenesis: A Potential Tool for Early Diagnosis in Alzheimer's Disease?

  2010cites this paper
• Polymorphic C-terminal β-Sheet Interactions Determine the Formation of Fibril or Amyloid β-derived Diffusible Ligand-like Globulomer for the Alzheimer Aβ42 Dodecamer*

  2010cites this paper
• Transmembrane structures for Alzheimer's Aβ(1-42) oligomers.

  2010cites this paper
• A Molecular Dynamics Study of Interactions between Amyloid-β Peptides and Model Lipid Membranes

  2010cites this paper
• Simultaneous single-molecule fluorescence and conductivity studies reveal distinct classes of Abeta species on lipid bilayers.

  2010cites this paper
• Lipid membranes and beta-amyloid: a harmful connection.

  2010cites this paper
• Strategies for the Inhibition of Protein Aggregation in Human Diseases

  2010cites this paper
• FK506 Reduces Amyloid Plaque Burden and Induces MMP-9 in AβPP/PS1 Double Transgenic Mice

  2010cites this paper
• Antimicrobial protegrin-1 forms ion channels: molecular dynamic simulation, atomic force microscopy, and electrical conductance studies.

  2010cites this paper
• Polymorphism in Alzheimer Aβ Amyloid Organization Reflects Conformational Selection in a Rugged Energy Landscape

  2010cites this paper
• Amyloid precursor protein, heat-shock proteins, and Bcl-2 form a complex in mitochondria and modulate mitochondria function and apoptosis in N2a cells.

  2009cites this paper
• Poloxamer 188 copolymer membrane sealant rescues toxicity of amyloid oligomers in vitro.

  2009cites this paper
• Alzheimer’s β-Amyloid-Induced Depolarization of Skeletal Muscle Fibers: Implications for Motor Dysfunctions in Dementia

  2009cites this paper
• Amyloid β‐protein fragments 25–35 and 31–35 potentiate long‐term depression in hippocampal CA1 region of rats in vivo

  2009cites this paper
• Misfolded amyloid ion channels present mobile beta-sheet subunits in contrast to conventional ion channels.

  2009cites this paper
• Fluorescence microscopy studies on the fibrillation of IAPP at model and cellular lipid interfaces, from mechanism to potential strategies in type II diabetes mellitus

  2009cites this paper
• Interactions between the amyloid precursor protein C‐terminal domain and G proteins mediate calcium dysregulation and amyloid β toxicity in Alzheimer’s disease

  2009cites this paper
• Size and morphology of toxic oligomers of amyloidogenic proteins: a case study of human stefin B

  2008cites this paper
• Spontaneous beta-barrel formation: an all-atom Monte Carlo study of Abeta16-22 oligomerization.

  2008cites this paper
• Models of toxic beta-sheet channels of protegrin-1 suggest a common subunit organization motif shared with toxic alzheimer beta-amyloid ion channels.

  2008cites this paper
• Spontaneous β‐barrel formation: An all‐atom Monte Carlo study of Aβ16–22 oligomerization

  2008cites this paper
• Interaction with model membranes and pore formation by human stefin B – studying the native and prefibrillar states

  2008cites this paper
• New structures help the modeling of toxic amyloidbeta ion channels.

  2008cites this paper
• Heterogeneous amyloid-formed ion channels as a common cytotoxic mechanism

  2007cites this paper
• Abeta ion channels. Prospects for treating Alzheimer's disease with Abeta channel blockers.

  2007cites this paper
• Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process.

  2007cites this paper
• Effect of Abeta exposure on the mRNA expression patterns of voltage-sensitive calcium channel alpha 1 subunits (alpha 1A-alpha 1D) in human SK-N-SH neuroblastoma.

  2006cites this paper
• Early and late cytotoxic effects of external application of the Alzheimer's Abeta result from the initial formation and function of Abeta ion channels.

  2006cites this paper
• The role of the endoplasmic reticulum in the accumulation of beta-amyloid peptide in Alzheimer's disease.

  2006cites this paper